Dr Reddys Buy Hold or Sell Recommendation

RDY -- USA Stock  

USD 38.01  1.10  2.81%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Dr Reddys Laboratories Ltd is 'Buy'. Macroaxis provides Dr Reddys buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RDY positions. The advice algorithm takes into account all of Dr Reddys Laboratories available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from RDY buy-and-hold prospective. Additionally take a look at Dr Reddys Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Dr ReddysBuy Dr Reddys
Buy

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

For the selected time horizon Dr Reddys Laboratories Ltd has a risk adjusted performance of 0.0758, jensen alpha of 0.102, total risk alpha of 0.0793, sortino ratio of 0.0623 and treynor ratio of 0.2443
Dr Reddys Laboratories buy or sell advice module can be used to check and cross-verify current buy, hold, or sell suggestion provided by analysts reviewing the organization potential to grow using all of fundamental, technical, data market data available right now. To make sure Dr Reddys Laboratories is not overpriced, please confirm all Dr Reddys Laboratories Ltd fundamentals including its Number of Shares Shorted, Current Ratio, Current Asset, as well as the relationship between EBITDA and Number of Employees . Given that Dr Reddys Laboratories has Price to Book of 3.28X, we urge you verify Dr Reddys market performance and probability of bankruptcy to make sure the company can sustain itself in the future given your latest risk tolerance and investing horizon.

Dr Reddys Trading Alerts and Improvement Suggestions

Dr Reddys current analysts recommendations

Target Median Price36.25
Target Mean Price36.25
Recommendation Mean4.00
Target High Price39.00
Number Of Analyst Opinions2
Target Low Price33.50

Dr Reddys Returns Distribution Density

Mean Return0.12Value At Risk2.49
Potential Upside2.83Standard Deviation1.51
 Return Density 
      Distribution 

Dr Reddys Greeks

α
Alpha over DOW
=0.10
β
Beta against DOW=0.45
σ
Overall volatility
=1.50
Ir
Information ratio =0.06

Dr Reddys Volatility Alert

Dr Reddys Laboratories Ltd has relatively low volatility with skewness of 0.16 and kurtosis of 0.33. However, we advise all investors to independently investigate Dr Reddys Laboratories Ltd to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Dr Reddys to competition

Dr Reddys Fundamental Vs Peers

FundamentalsDr ReddysPeer Average
Return On Equity15.08% (0.31)%
Return On Asset5.42% (0.14)%
Profit Margin13.45% (1.27)%
Current Valuation6.31B16.62B
Shares Outstanding165.72M571.82M
Shares Owned by Institutions13.64% 39.21%
Number of Shares Shorted1.68M4.71M
Price to Earning27.07X28.72X
Price to Book3.28X9.51X
Price to Sales2.86X11.42X
Revenue2.17B9.43B
Gross Profit83.43B27.38B
EBITDA429.93M3.9B
Net Income233.41M570.98M
Cash and Equivalents283.41M2.7B
Cash per Share1.71X5.01X
Total Debt811.73M5.32B
Debt to Equity23.50% 48.70%
Current Ratio1.89X2.16X
Book Value Per Share11.57X1.93K
Cash Flow from Operations75.58M971.22M
Short Ratio7.68X4.00X
Earnings Per Share1.40X3.12X
Price to Earnings To Growth1.67X4.89X
Number of Employees21.97K18.84K
Beta0.16-0.15
Market Capitalization6.39B19.03B
Total Asset3.14B29.47B
Retained Earnings1.5B9.33B
Working Capital831M1.48B
Current Asset1.81B9.34B
Current Liabilities976M7.9B
Z Score4.28.72
Search macroaxis.com